Cargando…
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Type 2 diabetes (T2D) is associated with an increased risk of cardiovascular disease (CVD). The gut microbiota may contribute to the onset and progression of T2D and CVD. The aim of this study was to evaluate the relationship between the gut microbiota and subclinical CVD in T2D patients. This cross...
Autores principales: | Tsai, Hui-Ju, Tsai, Wei-Chung, Hung, Wei-Chun, Hung, Wei-Wen, Chang, Chen-Chia, Dai, Chia-Yen, Tsai, Yi-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397936/ https://www.ncbi.nlm.nih.gov/pubmed/34444839 http://dx.doi.org/10.3390/nu13082679 |
Ejemplares similares
-
The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus
por: Hung, Wei-Chun, et al.
Publicado: (2021) -
Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
por: Tsai, Hui-Ju, et al.
Publicado: (2021) -
Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus
por: Pai, Che-Sheng, et al.
Publicado: (2022) -
Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
por: Tsai, Hui-Ju, et al.
Publicado: (2023) -
The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dai, Chia-Yen, et al.
Publicado: (2022)